Side effects include:
Adverse effects may include respiratory depression, local irritation, tissue inflammation, injection site infection, febrile response, chemical phlebitis, venospasm, hypervolemia, IV thrombosis, extravasation (with possible necrosis and sloughing of tissues), transient decreases in blood glucose concentrations, hypoglycemia, and hepatocellular necrosis with infusion via low-lying umbilical venous catheters.  (See Warnings under Cautions.)
Frequency not reported: Chemical phlebitis, venospasms
Frequency not reported: Extravasation tissue damage and sloughing
Frequency not reported: Transient depression of blood glucose
Frequency not reported: Hepatocellular necrosis
Frequency not reported: Infection at site of injection, venous thrombosis or phlebitis from site of injection extravasation
Frequency not reported: Hypervolemia
Frequency not reported: Febrile response
Frequency not reported: Ventilatory depression, respiratory depression
It is possible that some side effects of Tham may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.